Antimicrobial Effect of Low-Fluoride Toothpastes Containing Polyphosphate and Polyols: An In Vitro Assessment of Inhibition Zones
by
, , and
Igor Zen
1, 
Alberto Carlos Botazzo Delbem
1,
Thayse Yumi Hosida
1,
Caio Sampaio
1,
Leonardo Antônio de Morais
1,
Tamires Passadori Martins
1,
Douglas Roberto Monteiro
1,2 and
Juliano Pelim Pessan
1,* 1
Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil
2
Postgraduate Program in Health Sciences, University of Western São Paulo (UNOESTE), Presidente Prudente 19050-920, SP, Brazil
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(8), 1333; https://doi.org/10.3390/antibiotics12081333
Submission received: 3 May 2023
/
Revised: 17 May 2023
/
Accepted: 19 May 2023
/
Published: 18 August 2023
(This article belongs to the Special Issue Synthesis and Biological Activity of Antimicrobial Agents, 2nd Volume)
Abstract
:This study evaluated the antimicrobial effect of toothpastes containing 200 ppm fluoride (200F), xylitol (X, 16%), erythritol (E, 4%), and sodium trimetaphosphate (TMP, 0.25%), alone or in different associations, against Streptococcus mutans (SM), Lactobacillus casei (LC), Actinomyces israelii (AI), and Candida albicans (CA). Suspensions of the micro-organisms were added to a BHI Agar medium. Five wells were made on each plate to receive toothpaste suspensions at different dilutions. Toothpastes containing no actives (placebo) or 1100 ppm F (1100F) were used as negative and positive controls. Two-way ANOVA and Tukey’s HDS test were used (p < 0.05). For SM, the largest halo was for 200F+TMP at all dilutions, followed by the 200F+X+E toothpaste (p < 0.001). For LC, the overall trend showed that the polyols effectively inhibited microbial growth, and the association with the other compounds enhanced such effects (p < 0.001). For AI, a less-defined trend was observed. For CA, the experimental toothpaste (200F+X+E+TMP) was consistently more effective than the other treatments, followed by 200F+X+E (p < 0.001). The association of polyols and TMP in a low-fluoride toothpaste effectively reduced the growth of cariogenic micro-organisms (SM, CA, and LC), suggesting that this formulation could be an interesting alternative for children due to its low fluoride content.
1. Introduction
Dental caries is a chronic, biofilm-modulated disease, which has increasingly affected children worldwide [1], being associated with an increase in fermentable carbohydrates intake, and deficient removal or disorganization of dental biofilm. It is a sucrose-dependent biofilm disease, whose onset is related to the interaction of acidogenic and aciduric micro-organisms in the oral cavity [2].
Among the main micro-organisms involved, Streptococcus mutans stand out for their ability to colonize dental surfaces, metabolize carbohydrates, and produce lactic acid [3]. Other bacteria are related to the disease’s onset and progression, including Lactobacillus and Actinomyces [4]. In addition, the fungus Candida albicans has been reported to contribute to the formation and development of cariogenic biofilms, especially in dentine cavities, as its proteolytic enzymes are able to break down collagen molecules [5,6].
The association of mechanical and chemical methods is an effective method to reduce biofilm formation [7,8,9]. Among them, toothpastes present in their composition active agents that have mineralizing and/or antimicrobial action, such as fluoride (F) [8,9]. Furthermore, the addition of phosphate salts to F-containing toothpastes has been shown to boost the effects of F. In vitro and in situ studies have shown that low-F toothpastes containing sodium trimetaphosphate (TMP) have similar effects to those of a conventional formulation (1100 ppm F) on enamel de- and re-mineralization [10,11], and on F and calcium levels in the dental biofilm [10,12]. In addition to its promising effects on enamel, combined treatments of TMP and F, administered as solutions, have also been demonstrated to substantially affect the metabolism and matrix composition of dual-species biofilms of C. albicans and S. mutans [13], which can be mainly explained by its chelating property that exerts an influence on the permeability of the bacterial cell wall [14,15].
Besides the strategies above, products of natural origin, such as polyols, are used as sugar substitutes, which have the ability to reduce the growth and attachment of S. mutans to surfaces and reduce the volume of dental biofilm [16]. Literature shows a synergism between xylitol and F on the inhibition of acid production by S. mutans, with significantly higher effects than the actives alone [17]. Furthermore, erythritol has been demonstrated to affect even further microbial parameters compared with xylitol, reducing the expression of bacterial genes involved in sucrose metabolism and the overall number of dental caries, and serving as a suitable matrix for subgingival air-polishing to replace traditional root scaling, affecting both caries- and periodontitis-related pathogens, besides being suggested as an interesting alternative due to the lack of adverse events associated with its usage [18,19,20]. Although the mechanism of erythritol is not fully understood, the antimicrobial effects of these polyols can be considered to be by the fructose phosphotransferase system, which leads the cell to a high consumption of energy, causing it to not produce enough energy for the necessary bacterial conservation [21,22,23].
Considering the advantages of the above-mentioned strategies used alone and the need to develop safer and more effective formulations for children, this study’s objective is to evaluate in vitro the antimicrobial effect of toothpastes containing F at low concentration (200 ppm), xylitol, erythritol, and TMP, alone or in different associations on the suppression of the growth of S. mutans, Lactobacillus casei, Actinomyces israelii, and C. albicans strains, by assessing inhibition zones in agar culture media. The study’s null hypothesis was that the antimicrobial effects of the toothpastes associating two or more compounds would not be significantly different from the toothpastes containing the isolated actives.
2. Results
Overall, for S. mutans, the largest inhibition halo was observed for 200F+TMP (Figure 1) in all dilutions (p < 0.001). Nonetheless, the effects of the polyols used together, as well as their association with 200 ppm F promoted larger zones of inhibition compared with the other groups (p < 0.001), with sustained effects for all the dilutions (Table 1).
For L. casei, the general pattern was that the polyols, alone or coadministered, were effective in inhibiting microbial growth, and their association with the other actives potentiated the antimicrobial effects (Table 2; p < 0.001). In this sense, larger inhibition halos were observed for toothpastes containing both polyols and F combined (at most all the dilutions), both polyols and TMP combined (for the dilutions 1:2, 1:4, and 1:8), and for the experimental toothpaste (at the 1:1, 1:2, and 1:4 dilution). In addition, for most of the dilutions, 1100F did not promote a significant effect on this strain (Figure 2; p > 0.05).
For A. israelii, no defined trend was observed for treatments at the 1:1, 1:2, and 1:4 dilutions (Table 3). For the remaining dilutions (1:8 and 1:16), toothpaste containing 200 ppm F promoted the largest zones of inhibition compared with the other treatments (p < 0.001). In general, dentifrices containing polyols, regardless of the combinations, were not capable of producing significant inhibition zones at most of the dilutions (p > 0.05).
Conversely, for C. albicans, the experimental toothpaste (containing all actives) promoted a consistently higher inhibitory effect than the other treatments for all dilutions (except for 1:8), followed by 200F+X+E (Table 4; p < 0.05).
3. Discussion
In this study, the antimicrobial effect of toothpastes containing 200 ppm F, xylitol (16%), erythritol (4%), and TMP (0.25%), isolated or in different associations on S. mutans, A. israelii, L. casei, and C. albicans, was determined using an in vitro screening model. The results show that the toothpastes containing two or more actives promoted significantly larger inhibition zones than the isolated compounds for most of the pairwise comparisons, whose effects depended on the strain analyzed. Thus, the null hypothesis was rejected.
S. mutans was one of the strains chosen due to its direct involvement in dental caries onset and progression. For this strain, while toothpastes containing TMP alone or F at low concentrations promoted only modest antimicrobial effects, the largest inhibition halos were achieved by the association between 200 ppm F+TMP, for all dilutions (Table 1; Figure 1). These findings show the synergism between the two compounds, which is in agreement with CFU data of C. albicans and S. mutans [13]. Furthermore, this association was shown to reduce the total biofilm biomass and extracellular matrix components, and also promoted the highest pH values both before and after cariogenic challenges [23]. In vitro and in situ studies have also shown that the association between F and TMP leads to synergistic effects on de- and re-mineralization [10,11,23], reason by which such combination was assessed in the present study.
On the other hand, xylitol and/or erythritol promoted modest reductions in S. mutans growth. Literature reports that xylitol affects S. mutans cells by inhibiting glycolytic enzymes, which leads to a reduction of growth and acid production [24]. For erythritol, however, its mechanism is not fully known, although data have observed a superior effect for this polyol for some caries-related endpoints in comparison to xylitol [18]. Despite the fact that the reasons for the small effects of the polyols on S. mutans in the present study are not apparent, it is possible that the effect of these actives on this bacterium would be related to their antibiofilm action (e.g., extracellular polysaccharides production) rather than an inhibitory effect. Moreover, data have demonstrated that the sensitivity of the S. mutans strains to polyols varied markedly, and some strains were more sensitive to xylitol and some to erythritol, leading to the assumption that the effects of these polyols may be strain-dependent [25]. In fact, other natural or natural-like products have been demonstrated to suppress the growth of S. mutans. A recent in vitro study showed that olive oil mouthwashes were able to inactivate S. mutans in a protocol simulating salivary dilutions in the oral cavity. In light of this trend, the combination of the polyols with other promising actives such as the above-mentioned one, in addition to their incorporation to other vehicles, could be an interesting alternative for verifying their antimicrobial effects [26].
As for L. casei, conflicting evidence on the effects of xylitol is available from clinical studies. While some authors showed that xylitol’s continued use promoted reductions in Lactobacillus counts in saliva [27,28,29], others showed that the use of xylitol-containing gum [30] or toothpaste [31] did not reduce Lactobacillus counts compared with control groups. The different methodologies, vehicles of administration, and study duration hinder a direct comparison between studies, as these variables may have impacted the results. In the present study, the largest inhibition zone was observed for the experimental and xylitol toothpastes (at a 1:1 dilution). Such effects might have resulted from xylitol’s action on this strain following a similar mechanism to that described for S. mutans, in which it is related to the phosphotransferase system that inhibits the conservation of the bacteria and further growth [32,33,34,35].
Regarding A. israelii, no striking pattern was observed among the groups on the inhibition halos compared with the placebo toothpaste, for any of the tested dilutions (Table 3, Figure 3). This is in accordance with previous results showing that xylitol in the presence of glucose did not inhibit the growth of Actinomyces [36]. This fact can be explained by the low acidogenicity and acid tolerance of this strain [21]. They also reflect the status of non-cariogenic micro-organisms compared with S. mutans and L. casei [21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37].
In contrast, C. albicans has recently been used in in vitro biofilm protocols to reproduce conditions that better resemble those of cariogenic biofilms in vivo [13,23] as this fungus has been identified in biofilms collected from individuals presenting cavitated caries lesions [6]. In the present study, the highest inhibition halos were promoted by the experimental toothpaste (at the 1:1, 1:2, and 1:4 dilutions; Table 4; Figure 4), so that the simultaneous action of all compounds could explain such effects. Previous studies have shown that xylitol presents an inhibitory effect on C. albicans growth [38], which is due to an impaired nutrient absorption required to maintain yeast viability. The inability of C. albicans cells in catabolizing or excreting xylitol products accumulated in the cytoplasm also explains such effects, as such products lead to an increased osmotic strength and cell swelling [39,40]. Regarding erythritol, this compound was shown to increase the effect of benzethonium chloride against C. albicans, leading to the assumption that erythritol can help to disperse biofilms, favoring the penetration of fungicidal agents and weakening the microbial bond to surfaces [41]. However, the literature on this topic is scarce, pointing to the need for more comprehensive studies on the relationship between erythritol and this fungus.
A previous study showed that the association of F (500 ppm) and TMP on a biofilm of S. mutans and C. albicans was shown to promote alterations on the extracellular matrix and biofilm architecture compared with 1100 ppm F without TMP [13]. Such effects were attributed to the interaction of these compounds, which directly acted on the inhibition of bacterial enzymes and the reduction of intra- and extra-cellular polysaccharide production [42,43]. Based on this rationale, it could be hypothesized that the inhibitory effect for both S. mutans and C. albicans in the present study would result from the interaction (in different associations) of xylitol, erythritol, TMP, and/or F, through different mechanisms. Previous studies reported that these compounds act on cell metabolism, affecting the cytoplasm [38], DNA and RNA [19], proteins, and carbohydrates of the extracellular matrix [13], and adherence to surfaces [40].
In recent years, special attention has been given to the search for novel strategies for the use of natural-based formulations for the control of caries-related variables. The anti-inflammatory and antimicrobial properties of some extracts have prompted the investigation of the incorporation of such compounds into mouthcare products such as mouthwashes and dentifrices. A recent clinical trial suggested that a dentifrice containing Red Brazilian Propolis did not interfere with the kinetics and bioavailability of the salivary F in samples, enabling its integration with the formulation without compromising its anticaries activity [44]. Another one found that a polyphenol-rich cranberry dentifrice influenced a species-level shift in the ecology of the oral microbiome, resulting in a microbial community less associated with dental caries [45]. In fact, a recent literature review has thoroughly summarized the main data on the use of organic toothpaste formulations, verifying a gap in the literature of clinical studies, which should be encouraged, in order to produce sufficient evidence to provide consumers with recommendations for daily use, based on both efficacy and biocompatibility [20].
In general, our data point to a significantly higher effect of the experimental toothpaste on the growth inhibition of most of the micro-organisms assessed. This supports the idea of the simultaneous administration of polyols, polyphosphate, and F at a reduced concentration (200 ppm F) as an alternative for managing cariogenic biofilms, especially for young children, as it would reduce systemic fluoride exposure, while sustaining its mineralizing effects (from F and TMP) and enhancing the antimicrobial effects (from all the actives) compared with a conventional (1100 ppm F) toothpaste. However, any extrapolations to clinical conditions would be extremely premature given the preliminary nature of the data obtained, and limitations inherent to the study protocol. Future studies with biofilms, especially formed on dental substrates, could bring important data in this regard.
Figure 1.
Inhibition zone promoted by the toothpaste containing 200 ppm fluoride + sodium trimetaphosphate (0.25%), at 1:16, on Streptococcus mutans. This figure illustrates a considerable zone of inhibition promoted by the toothpaste.
Figure 1.
Inhibition zone promoted by the toothpaste containing 200 ppm fluoride + sodium trimetaphosphate (0.25%), at 1:16, on Streptococcus mutans. This figure illustrates a considerable zone of inhibition promoted by the toothpaste.
Figure 2.
Inhibition zone promoted by the toothpaste containing 1100 ppm fluoride, at 1:16, on Lactobacillus casei. This figure illustrates the lack of effect of this formulation on the strain.
Figure 2.
Inhibition zone promoted by the toothpaste containing 1100 ppm fluoride, at 1:16, on Lactobacillus casei. This figure illustrates the lack of effect of this formulation on the strain.
Figure 3.
Inhibition zone promoted by the toothpaste containing xylitol, at 1:16, on Actinomyces israelii. This figure illustrates the lack of effect of this formulation on the strain.
Figure 3.
Inhibition zone promoted by the toothpaste containing xylitol, at 1:16, on Actinomyces israelii. This figure illustrates the lack of effect of this formulation on the strain.
Figure 4.
Inhibition zone promoted by the EXP (toothpaste containing 200 ppm of fluoride + xylitol (16%) + erythritol (4%) + sodium trimetaphosphate (0.25%)), at 1:1, on Candida albicans. This figure illustrates the substantial inhibition zone produced by this treatment.
Figure 4.
Inhibition zone promoted by the EXP (toothpaste containing 200 ppm of fluoride + xylitol (16%) + erythritol (4%) + sodium trimetaphosphate (0.25%)), at 1:1, on Candida albicans. This figure illustrates the substantial inhibition zone produced by this treatment.
4. Materials and Methods
The toothpastes were produced by Xlear Incorporation, American Fork, UT, USA, and contained in their composition the following actives: xylitol (X: 16%), erythritol (E: 4%), sodium trimetaphosphate (TMP: 0.25%), and sodium fluoride at 200 ppm F, alone or in different combinations. Formulations without any actives (placebo) or containing 1100 ppm F were also manufactured as controls. The groups were: (a) placebo (without any active compound; negative control toothpaste); (b) 1100 ppm F (positive control toothpaste); (c) 200 ppm F (200F); (d) TMP (0.25%); (e) 200F+TMP; (f) xylitol (16%); (g) erythritol (4%); (h) xylitol+erythritol; (i) 200F+xylitol+erythritol; (j) TMP+xylitol+erythritol; (k) 200F+TMP+xylitol+erythritol (experimental toothpaste).
4.1. Preparation of Toothpaste Slurries
Toothpaste slurries were produced by dispersing 10 g of each toothpaste in 10 mL of sterile deionized water (1:1). Serial dilutions of the slurry were made using sterile deionized water, to obtain four additional dilutions at 1:2, 1:4, 1:8, and 1:16 [46].
4.2. Antimicrobial Assay
Agar diffusion assays were performed with the reference strains of the American Type Culture Collection (ATCC): C. albicans (ATCC 10231), S. mutans (ATCC 25175), A. israelii (ATCC 10048), and L. casei (ATCC 393) [17]. These were reactivated from their original cultures in Agar Sabouraud Dextrose (ASD; Difco, Le Pont de Claix, France) for C. albicans, and in Brain and Heart Infusion Agar (BHI Agar; Difco) for S. mutans, A. israelli, and L. casei, and incubated in 5% CO2 at 37 °C, for 24 h. Following this, five colonies of each species were individually added to BHI broth and incubated at 37 °C for 18–24 h. Aliquots of 300 μL of each bacterial suspension (optical density of 0.6, and absorbance of 550 nm -107 CFU/mL for C. albicans, and 108 CFU/mL for S. mutans, A. israelii, and L. casei) was homogenized with 15 mL of BHI Agar at 45 °C. Subsequently, equidistant wells (n = 6) were made on agar using sterilized cylinders (4 mm in diameter) and filled with 80 µL of the slurries of each toothpaste, at dilutions of 1:1, 1:2, 1:4, 1:8, and 1:16 [46]. The plates were kept for 2 h at room temperature to allow the solutions to diffuse, and then incubated at 37 °C for 24 h. The experiments were performed in triplicate. For each inhibition halo, three independent measures were performed with the aid of a digital caliper (accuracy 0.01 mm) (MitutoyoCD-15B) [46].
4.3. Statistical Analysis
Data were analyzed using the STATISTICA software (version 8.0). Data were submitted to normality (Shapiro–Wilk) and homogeneity (Barlett) tests. The p values, respectively, for normality and homogeneity tests for each micro-organism were: S. mutans (p = 0.301; p = 0.970), C. albicans (p = 0.296; p = 0.816), L. casei (p < 0.05; p = 0.220), and A. israelii (p = 0.658; p = 0.990). Data were subjected to two-way Analysis of Variance (ANOVA), considering as variation factors toothpastes and dilutions, followed by the Tukey’s HSD test, adopting a significance level of 5%.
5. Conclusions
The association of TMP, F, xylitol, and erythritol was shown to be effective in reducing the growth of isolated cariogenic micro-organisms under most of the conditions studied (i.e., micro-organisms and dilutions), being, therefore, a promising alternative for controlling biofilms related to dental caries. Despite the promising trends found in this work, these results should be interpreted with caution given the study limitations due to the nature of the present protocol. In this sense, further assessments including a wider microbial variety and a combined biofilm evaluation with a substrate such as dental enamel should be performed in order to confirm the present trends.
Author Contributions
Conceptualization, I.Z., A.C.B.D., T.Y.H., D.R.M. and J.P.P.; methodology, I.Z., A.C.B.D., T.Y.H., D.R.M. and J.P.P.; validation, A.C.B.D., T.Y.H., D.R.M. and J.P.P.; formal analysis, I.Z. and J.P.P.; investigation, I.Z., T.Y.H., C.S., L.A.d.M. and T.P.M.; resources, A.C.B.D.; data curation, J.P.P.; writing—original draft preparation, I.Z. and J.P.P.; writing—review and editing, I.Z., A.C.B.D., T.Y.H., C.S., L.A.d.M., T.P.M., D.R.M. and J.P.P.; visualization, I.Z.; supervision, A.C.B.D., T.Y.H., D.R.M. and J.P.P.; project administration, I.Z. and J.P.P.; funding acquisition, A.C.B.D. All authors have read and agreed to the published version of the manuscript.
Funding
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)-Finance Code 001 (Ph.D. scholarship to the first author).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study are available upon request from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
References
- Kassebaum, N.J.; Smith, A.G.C.; Bernabé, E.; Fleming, T.D.; Reynolds, A.E.; Vos, T.; Murray, C.J.L.; Marcenes, W.; GBD 2015 Oral Health Collaborators. Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors. J. Dent. Res. 2017, 96, 380–387. [Google Scholar] [CrossRef] [PubMed]
- Machiulskiene, V.; Campus, G.; Carvalho, J.C.; Dige, I.; Ekstrand, K.R.; Jablonski-Momeni, A.; Maltz, M.; Manton, D.J.; Martignon, S.; Martinez-Mier, E.A.; et al. Terminology of Dental Caries and Dental Caries Management: Consensus Report of a Workshop Organized by ORCA and Cariology Research Group of IADR. Caries Res. 2020, 54, 7–14. [Google Scholar] [CrossRef]
- Klein, M.I.; Hwang, G.; Santos, P.H.S.; Campanella, O.H.; Koo, H. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Front. Cell. Infect. Microbiol. 2015, 5, 10. [Google Scholar] [CrossRef]
- Ribeiro, A.A.; Paster, B.J. Dental caries and their microbiomes in children: What do we do now? J. Oral Microbiol. 2023, 10, 2198433. [Google Scholar] [CrossRef]
- Falsetta, M.L.; Klein, M.I.; Colonne, P.M.; Scott-Anne, K.; Gregoire, S.; Pai, C.H.; Gonzalez-Begne, M.; Watson, G.; Krysan, D.J.; Bowen, W.H.; et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect. Immun. 2014, 82, 1968–1981. [Google Scholar] [CrossRef]
- Menon, L.U.; Scoffield, J.A.; Jackson, J.G.; Zhang, P. Candida albicans and Early Childhood Caries. Front. Dent. Med. 2022, 3, 849274. [Google Scholar] [CrossRef]
- Sampaio, C.; Delbem, A.C.B.; Paiva, M.F.; Zen, I.; Danelon, M.; Cunha, R.F.; Pessan, J.P. Amount of Dentifrice and Fluoride Concentration Influence Salivary Fluoride Concentrations and Fluoride Intake by Toddlers. Caries Res. 2020, 54, 234–241. [Google Scholar] [CrossRef] [PubMed]
- Valkenburg, C.; Else Slot, D.; Van der Weijden, G.A. What is the effect of active ingredients in dentifrice on inhibiting the regrowth of overnight plaque? A systematic review. Int. J. Dent. Hyg. 2020, 18, 128–141. [Google Scholar] [CrossRef] [PubMed]
- Walsh, T.; Worthington, H.V.; Glenny, A.M.; Marinho, V.C.C.; Jeroncic, A. Fluoride toothpastes of different concentrations for preventing dental caries. Cochrane Database Syst. Rev. 2019, 3, CD007868. [Google Scholar] [CrossRef]
- Takeshita, E.M.; Danelon, M.; Castro, L.P.; Sassaki, K.T.; Delbem, A.C.B. Effectiveness of a toothpaste with low fluoride content combined with trimetaphosphate on dental biofilm and enamel demineralization in situ. Caries Res. 2015, 49, 394–400. [Google Scholar] [CrossRef] [PubMed]
- Takeshita, E.M.; Danelon, M.; Castro, L.P.; Cunha, R.F.; Delbem, A.C.B. Remineralizing Potential of a Low Fluoride Toothpaste with Sodium Trimetaphosphate: An in situ study. Caries Res. 2016, 50, 571–578. [Google Scholar] [CrossRef]
- Amaral, J.G.; Pessan, J.P.; Souza, J.A.S.; Moraes, J.C.S.; Delbem, A.C.B. Cyclotriphosphate associated to fluoride increases hydroxyapatite resistance to acid attack. J. Biomed. Mater. Res.-Part B Appl. Biomater. 2018, 106, 2553–2564. [Google Scholar] [CrossRef]
- Cavazana, T.P.; Hosida, T.Y.; Pessan, J.P.; Sampaio, C.; Monteiro, D.R.; Delbem, A.C.B. Activity of sodium trimetaphosphate, associated or not with fluoride, on dual-species biofilms. Biofouling 2019, 35, 710–718. [Google Scholar] [CrossRef] [PubMed]
- Lee, R.M.; Hartman, P.A.; Olson, D.G.; Williams, F.D. Bactericidal and bacteriolytic effects of selected food-grade phosphates, using Staphylococcus aureus as a model system. J. Food Prot. 1994, 57, 276–283. [Google Scholar] [CrossRef] [PubMed]
- Klompmaker, S.H.; Kohl, K.; Fasel, N.; Mayer, A. Magnesium uptake by connecting fluid-phase endocytosis to an intracellular inorganic cation filter. Nat. Commun. 2017, 8, 1879. [Google Scholar] [CrossRef]
- Söderling, E.; Pienihäkkinen, K. Effects of xylitol chewing gum and candies on the accumulation of dental plaque: A systematic review. Clin. Oral Investig. 2022, 26, 119–129. [Google Scholar] [CrossRef] [PubMed]
- Maehara, H.; Iwami, Y.; Mayanagi, H.; Takahashi, N. Synergistic inhibition by combination of fluoride and xylitol on glycolysis by mutans streptococci and its biochemical mechanism. Caries Res. 2005, 39, 521–528. [Google Scholar] [CrossRef]
- De Cock, P.; Mäkinen, K.; Honkala, E.; Saag, M.; Kennepohl, E.; Eapen, A. Erythritol Is More Effective Than Xylitol and Sorbitol in Managing Oral Health Endpoints. Int. J. Dent. 2016, 2016, 9868421. [Google Scholar] [CrossRef]
- Janus, M.M.; Volgenant, C.M.C.; Brandt, B.W.; Buijs, M.J.; Keijser, B.J.F.; Crielaard, W.; Zaura, E.; Krom, B.P. Effect of erythritol on microbial ecology of in vitro gingivitis biofilms. J. Oral Microbiol. 2017, 9, 1337477. [Google Scholar] [CrossRef]
- Mazur, M.; Ndokaj, A.; Bietolini, S.; Nisii, V.; Duś-Ilnicka, I.; Ottolenghi, L. Green dentistry: Organic toothpaste formulations. A literature review. Dent. Med. Probl. 2022, 59, 461–474. [Google Scholar] [CrossRef]
- Tanzer, J.M.; Livingston, J.; Thompson, A.M. The Microbiology of Primary Dental Caries in Humans. J. Dent. Educ. 2001, 65, 1028–1037. [Google Scholar] [CrossRef] [PubMed]
- Trahan, L. Xylitol: A review of its action on mutans streptococci and dental plaque--its clinical significance. Int. Dent. J. 1995, 45, 77–92. [Google Scholar]
- Cavazana, T.P.; Pessan, J.P.; Hosida, T.Y.; Sampaio, C.; Amarante, V.O.Z.; Monteiro, D.R.; Delbem, A.C.B. Effects of Sodium Trimetaphosphate, Associated or Not with Fluoride, on the Composition and pH of Mixed Biofilms, before and after Exposure to Sucrose. Caries Res. 2020, 54, 358–368. [Google Scholar] [CrossRef] [PubMed]
- Söderling, E.M.; Hietala-Lenkkeri, A.M. Xylitol and erythritol decrease adherence of polysaccharide-producing oral streptococci. Curr. Microbiol. 2010, 60, 25–29. [Google Scholar] [CrossRef]
- Loimaranta, V.; Mazurel, D.; Deng, D.; Söderling, E. Xylitol and erythritol inhibit real-time biofilm formation of Streptococcus mutans. BMC Microbiol. 2020, 29, 184. [Google Scholar] [CrossRef] [PubMed]
- Nardi, G.M.; Fais, S.; Casu, C.; Mazur, M.; Di Giorgio, R.; Grassi, R.; Grassi, F.R.; Orrù, G. Mouthwash Based on Ozonated Olive Oil in Caries Prevention: A Preliminary In-Vitro Study. Int. J. Environ. Res. Public Health 2020, 17, 9106. [Google Scholar] [CrossRef]
- Mäkinen, K.; Alanen, P.; Isokangas, P.; Isotupa, K.; Söderling, E.; Mäkinen, P.L.; Wenhui, W.; Weijian, W.; Chen, X.; Wei, Y.; et al. Thirty-nine-month xylitol chewing-gum programme in initially 8-year-old school children: A feasibility study focusing on mutans streptococci and lactobacilli. Int. Dent. J. 2008, 58, 41–50. [Google Scholar] [CrossRef]
- Mäkinen, K.; Chen, C.; Mäkinen, P.; Bennett, C.; Isokangas, P.; Isotupa, K.; Pape, H. Properties of whole saliva and dental plaque in relation to 40-month consumption of chewing gums containing xylitol, sorbitol or sucrose. Caries Res. 1996, 30, 180–188. [Google Scholar] [CrossRef]
- Mäkinen, K.K.; Bennett, C.A.; Hujoel, P.P.; Isokangas, P.J.; Isotupa, K.P.; Pape, H.R., Jr.; Makinen, P.L. Xylitol chewing gums and caries rates: A 40-month cohort study. J. Dent. Res. 1995, 74, 1904–1913. [Google Scholar] [CrossRef]
- Söderling, E.; Hirvonen, A.; Karjalainen, S.; Fontana, M.; Catt, D.; Seppä, L. The Effect of xylitol on the composition of the oral flora: A pilot study. Eur. J. Dent. 2011, 5, 24–31. [Google Scholar] [CrossRef] [PubMed]
- Maden, E.; Altun, C.; Ozmen, B.; Basak, F. Antimicrobial Effect of Toothpastes Containing Fluoride, Xylitol, or Xylitol-Probiotic on Salivary Streptococcus mutans and Lactobacillus in Children. Niger. J. Clin. Pract. 2018, 21, 134–138. [Google Scholar] [PubMed]
- Hausman, S.; Thompson, J.; London, J. Futile Xylitol Cycle in Lactobacillus casei. J. Bacteriol. 1984, 160, 211–215. [Google Scholar] [CrossRef] [PubMed]
- Helanto, M.; Aarnikunnas, J.; Palva, A.; Leisola, M.; Nyyssölä, A. Characterization of genes involved in fructose utilization by Lactobacillus fermentum. Arch. Microbiol. 2006, 186, 51–59. [Google Scholar] [CrossRef]
- London, J.; Hausman, S. Xylitol-Mediated Transient Inhibition of Ribitol Utilization by Lactobacillus casei. J. Bacteriol. 1982, 150, 657–661. [Google Scholar] [CrossRef] [PubMed]
- Radmerikhi, S.; Azul, E.; Fajardo, K.R.; Formantes, B. Antimicrobial effect of different xylitol concentrations on Streptococcus mutans and Lactobacillus acidophilus count. J. Restor. Dent. 2013, 1, 95. [Google Scholar] [CrossRef]
- Vadeboncoeur, C.; Trahan, L.; Mouton, C.; Mayrand, D. Effect of xylitol on the growth and glycolysis of acidogenic oral bacteria. J. Dent. Res. 1983, 62, 882–884. [Google Scholar] [CrossRef]
- Yadav, K.; Prakash, S. Dental Caries: A Microbiological Approach. J. Clin. Infect. Dis. Pract. 2017, 2, 118. [Google Scholar] [CrossRef]
- Talattof, Z.; Azad, A.; Zahed, M.; Shahradnia, N. Antifungal activity of Xylitol against Candida albicans: An in vitro study. J. Contemp. Dent. Pract. 2018, 19, 125–129. [Google Scholar] [CrossRef]
- Ameglio, F.; Di Giorgio, C.; Terzaroli, P.; Gandolfo, G.M. “Giant cell” production by C. albicans cultured in xylitol. Microbiologica 1990, 13, 343–346. [Google Scholar]
- Leepel, L.; Sastra, S.; Puspitawati, R.; Bachtiar, B. Effect of Xylitol with Various Concentration and Duration on the Growth of Candida albicans (In Vitro study). J. Dent. Indones. 2012, 16, 72–76. [Google Scholar] [CrossRef]
- Ichikawa, T.; Yano, Y.; Fujita, Y.; Kashiwabara, T.; Nagao, K. The enhancement effect of three sugar alcohols on the fungicidal effect of benzethonium chloride toward Candida albicans. J. Dent. 2008, 36, 965–968. [Google Scholar] [CrossRef] [PubMed]
- Koo, H.; Sheng, J.; Nguyen, P.T.M.; Marquis, R.E. Co-operative inhibition by fluoride and zinc of glucosyl transferase production and polysaccharide synthesis by mutans streptococci in suspension cultures and biofilms. FEMS Microbiol. Lett. 2006, 254, 134–140. [Google Scholar] [CrossRef] [PubMed]
- Pandit, S.; Kim, J.E.; Jung, K.H.; Chang, K.W.; Jeon, J.G. Effect of sodium fluoride on the virulence factors and composition of Streptococcus mutans biofilms. Arch. Oral Biol. 2011, 56, 643–649. [Google Scholar] [CrossRef] [PubMed]
- Girão Júnior, F.J.; Valadas, L.A.R.; Bottenberg, P.; Lotif, M.A.L.; Rodrigues Neto, E.M.; Fonseca, S.G.D.C.; Bandeira, M.A.M.; Squassi, A.; Dantas, T.C.F.B.; de Sena, N.J.C.; et al. Salivary Fluoride Bioavailability after Brushing with Brazilian Red Propolis Dentifrice: A Clinical Study. Evid. Based. Complement. Alternat. Med. 2022, 31, 6148137. [Google Scholar] [CrossRef]
- Philip, N.; Leishman, S.J.; Bandara, H.M.H.N.; Healey, D.L.; Walsh, L.J. Randomized Controlled Study to Evaluate Microbial Ecological Effects of CPP-ACP and Cranberry on Dental Plaque. JDR Clin. Trans. Res. 2020, 5, 118–126. [Google Scholar] [CrossRef] [PubMed]
- Malhotra, R.; Shashikiran, N. Comparison of Antimicrobial Activity of Child Formula Dentifrices at different Concentrations: An in vitro Study. Int. J. Clin. Pediatr. Dent. 2017, 10, 131–135. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Streptococcus mutans.
Table 1.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Streptococcus mutans.
| Toothpaste Dilutions (in Deionized Water) | |||||
|---|---|---|---|---|---|
| Groups | D1 | D2 | D4 | D8 | D16 |
| PLA | 12.7 ± 0.3 Aa (11.8–13.6) | 10.4 ± 0.4 Bab (9.4–11.5) | 10.5 ± 0.8 Ba (8.7–12.4) | 10.5 ± 0.5 Bab (9.3–11.6) | 10.3 ± 0.5 Bab (9.1–11.6) |
| X | 10.8 ± 0.6 Ab (9.2–12.3) | 10.4 ± 0.5 Aab (9.0–11.7) | 10.2 ± 0.4 Aa (9.2–11.2) | 10.1 ± 0.3 Ab (9.4–10.8) | 10.0 ± 0.3 Aab (9.5–10.7) |
| E | 10.2 ± 0.2 Ab (9.8–10.6) | 10.5 ± 0.5 Aab (9.2–11.6) | 10.3 ± 0.4 Aa (9.1–11.4) | 10.5 ± 0.5 Aab (9.4–11.5) | 9.8 ± 0.2 Ab (9.3–10.1) |
| TMP | 10.8 ± 0.2 Ab (10.3–11.1) | 10.5 ± 0.5 Bab (9.3–11.7) | 10.3 ± 0.4 Ba (8.6–11.9) | 10.6 ± 0.4 Bab (9.4–11.7) | 10.4 ± 0.3 Bab (9.4–11.0) |
| 200F | 10.2 ± 0.6 Ab (12.2–11.5) | 12.2 ± 0.6 Bb (11.5–12.6) | 11.7 ± 0.1 BCb (11.7–11.8) | 11.7 ± 0.4 BCc (11.6–12.0) | 11.9 ± 0.4 Cc (11.8–14.1) |
| 1100F | 11.1 ± 0.4 Ab (10.0–11.9) | 11.2 ± 0.2 Aab (10.6–11.5) | 11.1 ± 0.4 Aa (10.8–11.4) | 11.6 ± 0.3 Aac (11.4–11.7) | 11.3 ± 0.3 Aa (10.7–11.9) |
| X+E | 11.4 ± 0.8 Aab (9.3–13.3) | 10.2 ± 0.5 Aa (8.9–11.4) | 11 ± 0.5 Aa (9.9–12.0) | 10.5 ± 0.5 Aab (9.4–11.5) | 10.2 ± 0.2 Aab (9.7–10.5) |
| 200F+TMP | 21.1 ± 0.2 Ac (20.9–21.2) | 20.3 ± 0.4 Bc (19.2–21.5) | 19.9 ± 0.3 Bc (19.7–20.0) | 19.5 ± 0.5 Bd (19.4–19.9) | 19.2 ± 0.2 Bd (19.1–19.4) |
| 200F+X+E | 11.4 ± 0.4 Aab (10.3–12.4) | 11.4 ± 0.3 Ab (11.2–12.6) | 11.3 ± 0.4 Cb (11.1–11.5) | 11.3 ± 0.3 Cc (11.0–11.4) | 11.2 ± 0.3 Cc (11.1–11.3) |
| TMP+X+E | 11.1 ± 0.6 Ab (9.5–12.6) | 11.0 ± 0.5 Aab (9.8–12.1) | 10.7 ± 0.5 Aa (9.5–11.8) | 10.6 ± 0.5 Aab (9.4–11.7) | 10.4 ± 0.6 Aab (8.8–12.0) |
| EXP | 10.7 ± 0.4 Ab (9.3–12.0) | 10.2 ± 0.2 Aa (9.3–11.0) | 10.2 ± 0.6 Aa (9.9–11.1) | 10.1 ± 0.4 Aab (10.0–10.4) | 10.0 ± 0.5 Ab (10.0–10.5) |
Means ± standard deviations of the means (95% Confidence Intervals). Distinct capital letters indicate statistical differences among dilutions within each group. Distinct lower-case letters indicate statistical differences among each study group within each dilution (two-way ANOVA and Tukey’s HSD test, p < 0.05; n = 9). PLA: Placebo, X: Xylitol (16%), E: Erythritol (4%), TMP: Sodium Trimetaphosphate (0.25%), 200F: 200 ppm Fluoride, 1100F: 1100 ppm Fluoride, X+E: Xylitol (16%) + Erythritol (4%), 200F+TMP: 200 ppm Fluoride + Sodium Trimetaphosphate (0.25%), 200F+X+E: 200 ppm Fluoride + Xylitol (16%) + Erythritol (4%), TMP+X+E: Sodium Trimetaphosphate (0.25%) + Xylitol (16%) + Erythritol (4%), EXP: 200 ppm of Fluoride + Xylitol (16%) + Erythritol (4%) + Sodium Trimetaphosphate (0.25%).
Table 2.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Lactobacillus casei.
Table 2.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Lactobacillus casei.
| Toothpaste Dilutions (in Deionized Water) | |||||
|---|---|---|---|---|---|
| Groups | D1 | D2 | D4 | D8 | D16 |
| PLA | 13.4 ± 0.3 Aab (12.6–14.2) | 12.0 ± 0.1 Ba (11.8–12.1) | 12.0 ± 0.4 Bab (10.8–13.4) | 11.2 ± 0.2 Bab (10.5–11.8) | 6.5 ± 0.4 Ca (5.4–7.4) |
| X | 15.4 ± 0.2 Ad (14.7–16.0) | 12.9 ± 0.1 Bab (12.6–13.1) | 12.0 ± 0.4 Babc (11.1–13.0) | 11.9 ± 0.2 Bb (11.5–12.1) | 6.5 ± 0.2 Ca (5.9–7.1) |
| E | 13.1 ± 0.3 Aab (12.9–13.2) | 13.4 ± 0.4 Ab (13.4–13.8) | 11.4 ± 0.4 Ba (10.2–12.5) | 11.6 ± 0.3 Bab (11.4–11.7) | 11.8 ± 0.3 Bb (11.5–11.8) |
| TMP | 12.8 ± 0.3 Abc (12.6–12.9) | 12.6 ± 0.1 ABab (12.4–12.7) | 13.2 ± 0.2 Ac (13.0–13.3) | 11.5 ± 0.9 Bab (9.2–13.6) | 6.5 ± 0.3 Ca (5.8–7.1) |
| 200F | 12.0 ± 0.1 Ac (11.5–12.3) | 12.3 ± 0.5 Aab (11.1–13.5) | 11.5 ± 0.5 Aa (11.0–11.6) | 6.7 ± 0.2 Bc (6.2–7.1) | 6.8 ± 0.2 Ba (6.3–7.1) |
| 1100F | 13.9 ± 0.2 Aa (13.4–14.4) | 12.9 ± 0.2 ABab (12.7–13.0) | 11.9 ± 0.6 Ba (11.0–12.7) | 10.7 ± 0.8 Ca (8.8–12.6) | 6.8 ± 0.2 Da (6.6–6.9) |
| X+E | 13.2 ± 0.1 Aab (13.0–13.3) | 13.2 ± 0.1 Ab (13.0–13.3) | 11.9 ± 0.1 Ba (11.6–12.2) | 10.8 ± 0.2 Bab (10.2–11.4) | 6.1 ± 0.7 Ca (4.4–7.7) |
| 200F+TMP | 11.9 ± 0.1 Ac (11.8–12.1) | 12.1 ± 0.2 Aa (11.9–12.2) | 11.9 ± 0.3 Aa (11.0–12.6) | 11.0 ± 0.2 ABab (10.8–11.1) | 9.9 ± 0.2 Bc (9.7–10.0) |
| 200F+X+E | 13.9 ± 0.2 Aab (13.4–14.4) | 13.4 ± 0.4 Bc (13.1–13.6) | 13.3 ± 0.4 Ac (13.2–13.5) | 11.5 ± 0.1 Cab (11.3–11.6) | 6.2 ± 0.3 Da (5.2–7.1) |
| TMP+X+E | 13.1 ± 0.2 Aab (12.9–13.2) | 14.8 ± 0.3 Bd (14.5–14.8) | 12.4 ± 0.9 Aabc (10.2–14.5) | 12.2 ± 1.0 Bd (12.6–17.7) | 6.5 ± 0.3 Ca (5.9–7.1) |
| EXP | 14.2 ± 0.2 Ad (14.0–14.4) | 13.5 ± 0.3 Bab (13.1–13.9) | 13.1 ± 0.3 Bbc (13.0–13.2) | 11.0 ± 0.2 Cab (10.8–11.1) | 9.3 ± 0.4 Dc (9.1–9.5) |
Means ± standard deviations of the means (95% Confidence Intervals). Distinct capital letters indicate statistical differences among dilutions within each group. Distinct lower-case letters indicate statistical differences among each study group within each dilution (two-way ANOVA and Tukey’s HSD test, p < 0.05; n = 9). PLA: Placebo, X: Xylitol (16%), E: Erythritol (4%), TMP: Sodium Trimetaphosphate (0.25%), 200F: 200 ppm Fluoride, 1100F: 1100 ppm Fluoride, X+E: Xylitol (16%) + Erythritol (4%), 200F+TMP: 200 ppm Fluoride + Sodium Trimetaphosphate (0.25%), 200F+X+E: 200 ppm Fluoride + Xylitol (16%) + Erythritol (4%), TMP+X+E: Sodium Trimetaphosphate (0.25%) + Xylitol (16%) + Erythritol (4%), EXP: 200 ppm of Fluoride + Xylitol (16%) + Erythritol (4%) + Sodium Trimetaphosphate (0.25%).
Table 3.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Actinomyces israelii.
Table 3.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Actinomyces israelii.
| Toothpaste Dilutions (in Deionized Water) | |||||
|---|---|---|---|---|---|
| Groups | D1 | D2 | D4 | D8 | D16 |
| PLA | 5.9 ± 0.1 Aa (5.8–6.1) | 5.6 ± 0.2 Aa (5.3–6.0) | 5.8 ± 0.3 Aa (5.2–6.5) | 6.1 ± 0.2 Aa (5.6–6.4) | 6.1 ± 0.1 Aa (5.8–6.4) |
| X | 5.9 ± 0.2 Aa (5.5–6.3) | 5.9 ± 0.1 Aa (5.7–6.1) | 6.1 ± 0.2 Aa (5.7–6.5) | 5.9 ± 0.1 Aa (5.6–6.2) | 6.0 ± 0.3 Aab (5.1–6.9) |
| E | 6.2 ± 0.1 Aa (6.2–6.2) | 6.1 ± 0.2 Aa (5.7–6.4) | 6.0 ± 0.2 Aa (5.7–6.4) | 5.9 ± 0.1 Aa (5.6–6.2) | 6.0 ± 0.1 Aab (5.5–6.3) |
| TMP | 5.9 ± 0.2 Aa (5.8–6.3) | 6.0 ± 0.4 Aa (5.6–6.4) | 5.9 ± 0.3 Aa (5.7–6.0) | 6.0 ± 0.2 Aa (5.4–6.6) | 5.9 ± 0.3 Aab (5.6–6.1) |
| 200F | 6.2 ± 0.1 Aa (6.0–6.3) | 5.8 ± 0.1 Aa (5.7–6.0) | 5.7 ± 0.1 Aa (5.2–6.1) | 6.7 ± 0.2 Bb (6.2–7.1) | 6.7 ± 0.4 Bc (6.2–6.9) |
| 1100F | 5.7 ± 0.3 Aa (5.5–6.0) | 6.0 ± 0.3 Aa (5.8–6.3) | 5.8 ± 0.2 Aa (5.4–6.2) | 5.9 ± 0.2 Aa (5.3–6.6) | 6.0 ± 0.2 Aab (6.0–6.2) |
| X+E | 6.0 ± 0.1 Aa (5.8–6.1) | 5.7 ± 0.2 Aa (5.2–6.2) | 5.8 ± 0.4 Aa (5.6–6.1) | 5.7 ± 0.3 Aa (5.4–6.0) | 5.9 ± 0.2 Aab (5.5–6.4) |
| 200F+TMP | 5.7 ± 0.2 Aa (5.2–6.3) | 5.7 ± 0.2 Aa (5.2–6.2) | 5.6 ± 0.2 Aa (5.2–6.1) | 5.8 ± 0.3 Aa (5.3–6.3) | 5.5 ± 0.4 Ab (5.1–6.0) |
| 200F+X+E | 5.7 ± 0.2 Aa (5.3–6.2) | 5.8 ± 0.3 Aa (5.0–6.6) | 5.7 ± 0.3 Aa (5.5–6.0) | 5.9 ± 0.1 Aa (5.7–6.0) | 5.1 ± 0.2 Aab (5.6–6.1) |
| TMP+X+E | 6.0 ± 0.2 Aa (5.8–6.1) | 5.9 ± 0.1 Aa (5.7–6.2) | 5.8 ± 0.3 Aa (5.6–6.0) | 5.9 ± 0.3 Aa (5.7–6.0) | 5.9 ± 0.3 Aab (5.7–6.0) |
| EXP | 5.8 ± 0.1 Aa (5.6–5.9) | 6.0 ± 0.3 Aa (5.6–6.4) | 5.9 ± 0.1 Aa (5.8–6.1) | 5.9 ± 0.3 Aa (5.5–6.3) | 6.1 ± 0.3 Aa (5.8–6.4) |
Means ± standard deviations of the means (95% Confidence Intervals). Distinct capital letters indicate statistical differences among dilutions within each group. Distinct lower-case letters indicate statistical differences among each study group within each dilution (two-way ANOVA and Tukey’s HSD test, p < 0.05; n = 9). PLA: Placebo, X: Xylitol (16%), E: Erythritol (4%), TMP: Sodium Trimetaphosphate (0.25%), 200F: 200 ppm Fluoride, 1100F: 1100 ppm Fluoride, X+E: Xylitol (16%) + Erythritol (4%), 200F+TMP: 200 ppm Fluoride + Sodium Trimetaphosphate (0.25%), 200F+X+E: 200 ppm Fluoride + Xylitol (16%) + Erythritol (4%), TMP+X+E: Sodium Trimetaphosphate (0.25%) + Xylitol (16%) + Erythritol (4%), EXP: 200 ppm of Fluoride + Xylitol (16%) + Erythritol (4%) + Sodium Trimetaphosphate (0.25%).
Table 4.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Candida albicans.
Table 4.
Zone of inhibition of toothpastes containing different active compounds, at 5 dilutions, on Candida albicans.
| Toothpaste Dilutions (in Deionized Water) | |||||
|---|---|---|---|---|---|
| Groups | D1 | D2 | D4 | D8 | D16 |
| PLA | 5.6 ± 0.2 Aa (4.9–6.4) | 5.5 ± 0.1 Aa (5.1–5.9) | 5.6 ± 0.3 Aa (5.3–5.8) | 5.8 ± 0.7 Aa (5.7–6.0) | 5.6 ± 0.3 Aab (5.5–5.8) |
| X | 5.7 ± 0.1 Aa (5.6–5.9) | 5.7 ± 0.3 Aa (5.3–6.2) | 5.7 ± 0.3 Aa (4.9–6.4) | 5.9 ± 0.5 Aa (5.7–6.8) | 5.4 ± 0.4 Aa (5.2–5.5) |
| E | 5.9 ± 0.3 Aa (5.2–6.5) | 5.8 ± 0.3 Aa (5.4–6.2) | 5.9 ± 0.5 Aab (5.2–6.7) | 5.8 ± 0.3 Aa (5.0–6.6) | 5.9 ± 0.3 Aab (5.2–6.7) |
| TMP | 6.2 ± 0.2 Aab (5.5–6.9) | 5.1 ± 0.1 ABa (5.1–6.0) | 5.1 ± 0.2 ABab (5.0–6.1) | 5.4 ± 0.2 Ba (5.2–6.5) | 5.7 ± 0.5 ABab (5.3–6.1) |
| 200F | 5.8 ± 0.1 Aa (5.5–6.1) | 5.5 ± 0.1 Aa (5.1–5.9) | 5.6 ± 0.9 Aa (5.3–5.9) | 5.8 ± 0.1 Aa (5.4–6.2) | 5.6 ± 0.7 Aab (5.4–5.7) |
| 1100F | 6.1 ± 0.2 Aab (5.5–6.7) | 5.9 ± 0.2 Aab (5.7–6.2) | 6.1 ± 0.3 Aab (5.4–6.8) | 5.8 ± 0.2 Aa (5.4–6.3) | 5.8 ± 0.1 Aab (5.5–6.0) |
| X+E | 6.0 ± 0.5 Aab (5.8–6.3) | 5.1 ± 0.3 Aa (5.1–6.0) | 5.1 ± 0.2 Aa (5.1–5.4) | 5.1 ± 0.3 Aa (5.0–5.7) | 5.0 ± 0.9 Aab (5.0–5.4) |
| 200F+TMP | 5.8 ± 0.1 Aa (5.5–6.1) | 5.5 ± 0.4 Aa (5.1–5.9) | 5.6 ± 0.2 Aa (5.3–5.9) | 5.8 ± 0.1 Aa (5.4–6.2) | 5.6 ± 0.7 Aab (5.4–5.7) |
| 200F+X+E | 6.6 ± 0.1 ABb (6.4–6.7) | 6.6 ± 0.2 Bb (6.3–6.9) | 5.9 ± 0.4 ACab (5.6–6.2) | 5.7 ± 0.3 Ca (5.3–6.1) | 5.9 ± 0.2 ACab (5.3–6.5) |
| TMP+X+E | 5.7 ± 0.2 Aa (5.4–5.9) | 5.7 ± 0.2 Aa (5.2–6.2) | 5.8 ± 0.2 Aa (5.5–6.0) | 5.8 ± 0.1 Aa (5.5–6.5) | 5.7 ± 0.7 Aab (5.2–6.2) |
| EXP | 7.9 ± 0.4 Ac (6.7–9.1) | 7.6 ± 0.3 Ac (6.6–8.5) | 6.6 ± 0.2 Bb (6.1–7.1) | 6.0 ± 0.7 Ba (5.4–6.7) | 6.0 ± 0.1 Bb (5.9–6.5) |
Means ± standard deviations of the means (95% Confidence Intervals). Distinct capital letters indicate statistical differences among dilutions within each group. Distinct lower-case letters indicate statistical differences among the study groups within each dilution (two-way ANOVA and Tukey’s HSD test, p < 0.05; n = 9). PLA: Placebo, X: Xylitol (16%), E: Erythritol (4%), TMP: Sodium Trimetaphosphate (0.25%), 200F: 200 ppm Fluoride, 1100F: 1100 ppm Fluoride, X+E: Xylitol (16%) + Erythritol (4%), 200F+TMP: 200 ppm Fluoride + Sodium Trimetaphosphate (0.25%), 200F+X+E: 200 ppm Fluoride + Xylitol (16%) + Erythritol (4%), TMP+X+E: Sodium Trimetaphosphate (0.25%) + Xylitol (16%) + Erythritol (4%), EXP: 200 ppm of Fluoride + Xylitol (16%) + Erythritol (4%) + Sodium Trimetaphosphate (0.25%).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Zen, I.; Delbem, A.C.B.; Hosida, T.Y.; Sampaio, C.; de Morais, L.A.; Martins, T.P.; Monteiro, D.R.; Pessan, J.P. Antimicrobial Effect of Low-Fluoride Toothpastes Containing Polyphosphate and Polyols: An In Vitro Assessment of Inhibition Zones. Antibiotics 2023, 12, 1333. https://doi.org/10.3390/antibiotics12081333
AMA Style
Zen I, Delbem ACB, Hosida TY, Sampaio C, de Morais LA, Martins TP, Monteiro DR, Pessan JP. Antimicrobial Effect of Low-Fluoride Toothpastes Containing Polyphosphate and Polyols: An In Vitro Assessment of Inhibition Zones. Antibiotics. 2023; 12(8):1333. https://doi.org/10.3390/antibiotics12081333
Chicago/Turabian StyleZen, Igor, Alberto Carlos Botazzo Delbem, Thayse Yumi Hosida, Caio Sampaio, Leonardo Antônio de Morais, Tamires Passadori Martins, Douglas Roberto Monteiro, and Juliano Pelim Pessan. 2023. "Antimicrobial Effect of Low-Fluoride Toothpastes Containing Polyphosphate and Polyols: An In Vitro Assessment of Inhibition Zones" Antibiotics 12, no. 8: 1333. https://doi.org/10.3390/antibiotics12081333
APA StyleZen, I., Delbem, A. C. B., Hosida, T. Y., Sampaio, C., de Morais, L. A., Martins, T. P., Monteiro, D. R., & Pessan, J. P. (2023). Antimicrobial Effect of Low-Fluoride Toothpastes Containing Polyphosphate and Polyols: An In Vitro Assessment of Inhibition Zones. Antibiotics, 12(8), 1333. https://doi.org/10.3390/antibiotics12081333
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
